Drug intelligence / Profile preview

umbilical cord mesenchymal stem cells (ILBS)

Development stage
Unknown
Lead developer
Institute of Liver and Biliary Sciences
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intravenous
01

Overview

Umbilical cord mesenchymal stem cells (ucMSCs) developed by the Institute of Liver and Biliary Sciences (ILBS) in India are an investigational cell therapy being evaluated for the treatment of non-viral acute-on-chronic liver failure (ACLF). These cells are harvested from umbilical cord tissue and processed within a cGMP-compliant facility. The therapy is designed to promote native liver regeneration and provide a transplant-free treatment option for patients with ACLF, a condition with high mortality and limited donor organ availability. The mechanism of action involves the immunomodulatory and regenerative properties of MSCs, which can migrate to the site of liver injury, secrete trophic factors to reduce inflammation, and stimulate the repair of damaged hepatic tissue.

Other names
umbilical cord Mesenchymal Stem CellucMSCs

Beyond the preview

Go deeper on umbilical cord mesenchymal stem cells (ILBS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on umbilical cord mesenchymal stem cells (ILBS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call